Glenmede Trust’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-18,320
| Closed | -$406K | – | 1351 |
|
|
2021
Q2 | $406K | Sell |
18,320
-882
| -5% | -$18.7K | ﹤0.01% | 942 |
|
|
2021
Q1 | $504K | Buy |
19,202
+264
| +1% | +$6.28K | ﹤0.01% | 845 |
|
|
2020
Q4 | $353K | Buy |
18,938
+1,785
| +10% | +$33.3K | ﹤0.01% | 927 |
|
|
2020
Q3 | $291K | Buy |
17,153
+11,434
| +200% | +$222K | ﹤0.01% | 932 |
|
|
2020
Q2 | $133K | Buy |
5,719
+5,423
| +1,832% | +$78.6K | ﹤0.01% | 1097 |
|
|
2020
Q1 | $2K | Hold |
296
| – | – | ﹤0.01% | 2888 |
|
|
2019
Q4 | $2K | Sell |
296
-744
| -72% | -$6.99K | ﹤0.01% | 2888 |
|
|
2019
Q3 | $9 | Buy |
1,040
+499
| +92% | +$5.26K | ﹤0.01% | 2413 |
|
|
2019
Q2 | $6 | Sell |
541
-1,200
| -69% | -$14.5K | ﹤0.01% | 2588 |
|
|
2019
Q1 | $30 | Hold |
1,741
| – | – | ﹤0.01% | 1919 |
|
|
2018
Q4 | $29 | Buy |
+1,741
| New | +$29.7K | ﹤0.01% | 1834 |
|
|
2018
Q3 | – | Sell |
-1,200
| Closed | -$19K | – | 1895 |
|
|
2018
Q2 | $19K | Sell |
1,200
-210
| -15% | -$3.13K | ﹤0.01% | 1734 |
|
|
2018
Q1 | $18K | Hold |
1,410
| – | – | ﹤0.01% | 2006 |
|
|
2017
Q4 | $18K | Hold |
1,410
| – | – | ﹤0.01% | 2006 |
|
|
2017
Q3 | $20K | Hold |
1,410
| – | – | ﹤0.01% | 1970 |
|
|
2017
Q2 | $18K | Hold |
1,410
| – | – | ﹤0.01% | 1953 |
|
|
2017
Q1 | $18K | Buy |
1,410
+210
| +18% | +$2.94K | ﹤0.01% | 1953 |
|
|
2016
Q4 | $21K | Hold |
1,200
| – | – | ﹤0.01% | 1889 |
|
|
2016
Q3 | $23K | Hold |
1,200
| – | – | ﹤0.01% | 1899 |
|
|
2016
Q2 | $23K | Hold |
1,200
| – | – | ﹤0.01% | 1854 |
|
|
2016
Q1 | $24K | Hold |
1,200
| – | – | ﹤0.01% | 1766 |
|
|
2015
Q4 | $24K | Hold |
1,200
| – | – | ﹤0.01% | 1812 |
|
|
2015
Q3 | $20K | Sell |
1,200
-64
| -5% | -$1.17K | ﹤0.01% | 1902 |
|
|
2015
Q2 | $23K | Buy |
1,264
+64
| +5% | +$1.19K | ﹤0.01% | 1861 |
|
|
2015
Q1 | $22K | Sell |
1,200
-1,231
| -51% | -$22.8K | ﹤0.01% | 1920 |
|
|
2014
Q4 | $39K | Sell |
2,431
-2,709
| -53% | -$46.5K | ﹤0.01% | 1830 |
|
|
2014
Q3 | $90K | Sell |
5,140
-1,075
| -17% | -$21.1K | ﹤0.01% | 1508 |
|
|
2014
Q2 | $128K | Hold |
6,215
| – | – | ﹤0.01% | 1323 |
|
|
2014
Q1 | $135K | Sell |
6,215
-575
| -8% | -$13.2K | ﹤0.01% | 1317 |
|
|
2013
Q4 | $180K | Sell |
6,790
-125
| -2% | -$3.07K | ﹤0.01% | 1192 |
|
|
2013
Q3 | $163K | Hold |
6,915
| – | – | ﹤0.01% | 1207 |
|
|
2013
Q2 | $148K | Buy |
+6,915
| New | +$149K | ﹤0.01% | 1188 |
|
Other funds holding VIVO
RA
DM
SFM
Glenmede Trust's VIVO Position: Q3 2021 in Review
Glenmede Trust sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 18,320 shares — an estimated $406K sold.
Glenmede Trust first reported a position in VIVO in Q2 2013 and held it in 32 quarters. The position peaked at $504K in Q1 2021. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.
- Glenmede Trust reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
- Glenmede Trust sold 18,320 Meridian Bioscience Inc shares in Q3 2021, an estimated $406K.
- Glenmede Trust first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 32 quarters.
- Glenmede Trust's Meridian Bioscience Inc position peaked at $504K in Q1 2021.
- 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.
Based on Glenmede Trust's 13F filing for Q3 2021, filed 15 Nov 2021.